Positron Emission Tomography (PET)
Positron Emission Tomography (PET) is a medical procedure with 52 clinical trials. Currently 17 active trials ongoing. Historical success rate of 85.2%.
Success Metrics
Based on 23 completed trials
Phase Distribution
Phase Distribution
16
Early Stage
13
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.1%
23 of 28 finished
17.9%
5 ended early
17
trials recruiting
52
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
Understanding New Cachexia Subtypes Through Observational Epidemiological Research
Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer
Clinical Trials (52)
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
Understanding New Cachexia Subtypes Through Observational Epidemiological Research
Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer
A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer
Using FAPI PET/MRI to Evaluate Prostate Cancer
Multi-organ Imaging of Microvascular and Metabolic Function
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
64Cu-GRIP B in Patients With Advanced Malignancies
Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
Investigating the Brain's Physiological Responses in Depression and Autism, Using Transcranial Magnetic Stimulation and Electroencephalography
PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy
Cerebral Activation and Bilateral Stimulation by Cochlear Implantation in Bilateral Deaf Adults
Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 52